We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
EffRx Pharmaceuticals SA Signs Exclusive License Agreement with Pharmaxis for the Registration and Commercialization of Bronchitol® in Switzerland
The product portfolio is led by already launched Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with Us
Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.